Sponsored Content

Leading on Sustainability: Why Pharma Already Has the Operating Model to Deliver
Arcadis_Sustainability_in_Pharma_WP

Pharmaceutical manufacturing is nearly 50% more emissions intensive per dollar of revenue than the automotive sector. Yet for some medicines, up to 95% of emissions occur upstream, in raw material sourcing and production, long before a product reaches a patient. At the same time, confidence is eroding. In 2024, four in ten executives reported uncertainty about whether sustainability investments are delivering measurable returns. This is no longer a reporting challenge. It’s an operating model challenge.

Arcadis is a leading global partner, delivering some of the most transformative projects with businesses, cities and industries. With 34,000 people active in more than 30 countries, we bring together the best minds from around the world to deliver intelligent products and solutions across the environment, energy, water, buildings, transport and infrastructure sectors.

Download Sponsored Content

To download this sponsored content, complete the form below. Once submitted, you will receive a link via the email you provided to download the sponsored content.

Company Type

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.